Abstract:OBJECTIVES:We aimed to describe the anatomic distribution of periarterial pulmonary sympathetic nerves and to observe the long-term morphometric and functional changes after pulmonary artery denervation (PADN), a novel therapy for pulmonary arterial hypertension (PAH).METHODS:A total of 45 beagles were divided into a sympathetic innervation group (n = 3, 33.3% were females), a PAH group (n = 35, 34.3% were females) and a control group (n = 7, 28.5% were females). The PAH group was randomly divided into no-PADN (n = 7), instant-PADN (n = 7), 1M-PADN (n = 7), 2M-PADN (n = 7) and 3M-PADN (n = 7) subgroups. The sympathetic innervation group was sacrificed to reveal the sympathetic innervation of pulmonary arteries. PAH was induced by injecting dehydromonocrotaline (DHMCT) through the right atrium. The pulmonary capillary wedge pressure, right ventricular systolic pressure, right ventricular mean pressure, pulmonary artery systolic pressure and pulmonary artery mean pressure of each group were continuously measured. The cardiac output was detected to calculate the pulmonary vascular resistance. PAH and control groups were subjected to immunofluorescence assay, sympathetic nerve conduction velocity measurement and transmission electron microscopy.RESULTS:The no-PADN group had significantly higher PVSP, PVMP, pulmonary artery systolic pressure, pulmonary artery mean pressure and pulmonary vascular resistance but lower cardiac output than those of the control group (P < 0.05). Instant-PADN, 1M-PADN, 2M-PADN and 3M-PADN groups had significantly lower PVSP, PVMP, pulmonary artery systolic pressure, pulmonary artery mean pressure and pulmonary vascular resistance but higher cardiac output than those of the no-PADN group (P < 0.05). Most sympathetic nerves were located within 2.5 mm of the intimae of the bifurcation and proximal trunk, mainly in the left trunk. The diameter and cross-sectional area of myelinated fibres in the PAH group were significantly larger than those of the control group. Sympathetic nerve conduction velocity of the PAH group gradually decreased, and nerve fibres were almost demyelinated 3 months after PADN.CONCLUSIONS:PADN effectively relieved dehydromonocrotaline-induced canine PAH and decreased sympathetic nerve conduction velocity.

Noninvasive Stereotactic Radiotherapy for PADN in an Acute Canine Model of Pulmonary Arterial Hypertension

Noninvasive Stereotactic Radiotherapy for Renal Denervation in a Swine Model

Pulmonary Artery Denervation Attenuates Pulmonary Arterial Remodeling in Dogs With Pulmonary Arterial Hypertension Induced by Dehydrogenized Monocrotaline.

Renal Denervation By Noninvasive Stereotactic Radiotherapy Induces Persistent Reduction Of Sympathetic Activity In A Hypertensive Swine Model

Quantitative and Functional Changes of Circulating Endothelial Progenitor Cells in Dogs with Dehydromonocrotaline-Induced Pulmonary Artery Hypertension

A4888 an Imaging-based Renal Denervation Strategy in Hypertensive Canines Using Integrated Ultrasound Catheter

Sympathetic Innervation of Canine Pulmonary Artery and Morphometric and Functional Analysis in Dehydromonocrotaline-Induced Models after Pulmonary Artery Denervation.

Pulmonary Artery Denervation Inhibits Left Stellate Ganglion Stimulation-Induced Ventricular Arrhythmias Originating From the RVOT

Percutaneous Pulmonary Artery Denervation Completely Abolishes Experimental Pulmonary Arterial Hypertension in Vivo.

MRI-guided coronary catheterization and PTCA: A feasibility study on a dog model.

A retrospective analysis of stereotactic body radiation therapy for canine heart base tumors: 26 cases

Advances Of Stereotactic Body Radiotherapy In Pancreatic Cancer

Efficacy and Safety of A Novel Multi-Electrode Radiofrequency Ablation Catheter for Renal Sympathetic Denervation in Pigs

Establishment of a canine model of carotid stenosis suitable for stenting or percutaneous transluminal angioplasty

Short-term Safety and Efficiency of Cryoablation for Renal Sympathetic Denervation in a Swine Model.

Optimal Strategy for HIFU-Based Renal Sympathetic Denervation in Canines

Transthoracic Pulmonary Artery Denervation for Pulmonary Arterial Hypertension.

Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension

Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension: The Single-Center, Prospective, First-in-Man PADN-1 Study (First-in-Man Pulmonary Artery Denervation for Treatment of Pulmonary Artery Hypertension)

Effects of Renal Denervation Via Renal Artery Adventitial Cryoablation on Atrial Fibrillation and Cardiac Neural Remodeling.

Radiotherapy inhibits neointimal hyperplasia after artificial vascular replacement through Skp2/P27kip1